Nimbex (Cisatracurium)

Cisatracurium, the active ingredient in Nimbex, is a non-depolarizing neuromuscular blocking agent presented as an intravenous solution for intravenous use. It produces skeletal muscle relaxation by competitively antagonising nicotinic acetylcholine receptors, and is used to facilitate endotracheal intubation, maintain muscle relaxation during surgery, and support patients on mechanical ventilation.

GNH USA supplies Nimbex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Cisatracurium is a non‑depolarizing neuromuscular blocker used in peri‑operative and critical‑care settings to achieve controlled skeletal muscle relaxation.

- Endotracheal intubation: facilitates safe placement of the airway tube by providing rapid muscle relaxation. - Surgical procedures: maintains adequate muscle relaxation throughout general anesthesia for optimal surgical conditions. - Mechanical ventilation: sustains muscle relaxation in intubated patients requiring prolonged ventilatory support.

Cisatracurium may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Histamine release: flushing, erythema, or pruritus. - Transient hypotension: mild drop in blood pressure. - Bradycardia: slower heart rate. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with airway compromise. - Prolonged neuromuscular blockade: extended paralysis requiring ventilation. - Hyperkalemia: elevated serum potassium in susceptible patients. - Cardiac arrhythmias: irregular heart rhythms.

When using cisatracurium, clinicians should observe specific precautions to minimise risks and ensure optimal patient safety.

- Patient monitoring: continuously assess neuromuscular function and depth of blockade. - Histamine sensitivity: avoid rapid bolus in patients with known histamine reactions. - Renal/hepatic impairment: adjust dosing as drug metabolism may be altered. - Concurrent neuromuscular blockers: avoid additive effects with other agents. - Pregnancy and lactation: use only if benefit outweighs potential risk, as safety data are limited. - Store at ambient temperature: keep in original container, protect from light and moisture.

Cisatracurium can interact with several drugs, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Aminoglycoside antibiotics: may potentiate neuromuscular blockade. - Lithium: can enhance muscle relaxation and prolong effect. - Magnesium sulfate: increases risk of profound blockade.

Moderate Interactions (Monitor Closely): - Volatile anesthetics (e.g., sevoflurane): may augment blockade. - Inhaled nitrous oxide: can slightly increase effect. - Calcium channel blockers: may modify response.